A novel peptide excipient stabilizes DaxibotulinumtoxinA.

Surface adsorption of proteins in bulk drug product formulations and loss of protein structural integrity during manufacturing processes can diminish drug potency. In formulations containing low biologic drug substance, such as botulinum toxin type A…

Preview only. Read the full abstract at the source